Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fidaxomicin vs Vancomycin for C. difficile Decolonization in IBD
NCT06794944Phase 4Not yet recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Sep 2026
- Primary completion
- Sep 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fidaxomicin in Clostridioides difficile infection (CDI), sponsored by Brigham and Women's Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
fidaxomicin
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT06794944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06794944.